Aspire Biopharma Holdings, Inc. (ASBP) NASDAQ
0.21
+0.0159(+8.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.21
+0.0159(+8.08%)
Currency In USD
| Previous Close | 0.2 |
| Open | 0.21 |
| Day High | 0.24 |
| Day Low | 0.2 |
| 52-Week High | 35 |
| 52-Week Low | 0.16 |
| Volume | 55.71M |
| Average Volume | 4.8M |
| Market Cap | 736,187 |
| PE | -0.01 |
| EPS | -16.38 |
| Moving Average 50 Days | 1.09 |
| Moving Average 200 Days | 8.43 |
| Change | 0.02 |
An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation
Newsfile
Mar 11, 2025 12:00 PM GMT
SmallCaps Daily Dives Deep with CEO Kraig Higginson to Discuss Aspire's Mission to Enhance Efficacy and Reduce Side EffectsNew York, New York--(Newsfile Corp. - March 11, 2025) - Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) ("Aspire" or the "Compan